|
|
News
|
A letter from our valued partner LANXESS, supporting the use of Rely+On® Virkon® as a disinfectant for use on hard surfaces where transmission of pox viruses could be of any concern. Subject: Rely+On® Virkon® Efficacy claims: Monkey pox virus Dear Customer, We, Antec International Limited – A LANXESS Company,...
2021-05-12 Lanxess Press Release NEW efficacy test demonstrates Rely+On™ Virkon™ inactivates the SARS-CoV-2 virus (COVID-19) at an economical in-use dilution rate of 1:500 – 0.2%. With the powerful disinfectant already proven to rapidly kill the SARS-CoV-2 virus at a dilution of 1:100 -1%, in JUST 60 SECONDS on hard surfaces,...
2020-07-29 New study: LANXESS disinfectant kills coronavirus SARS-CoV-2 in just 60 seconds Efficacy of Rely+On Virkon scientifically proven Proven to protect against the COVID-19 virus Cologne – Rely+On Virkon broad spectrum disinfectant, produced by specialty chemicals company LANXESS, demonstrates extremely rapid efficacy against the SARS-CoV-2 virus. This is the finding...
2020-05-21 Introducing Rely+On™ Virkon™ broad spectrum disinfectant, the new name for Rely+On™ MDC in the U.S. human health market sector Effective disinfection for institutional, food processing and public service facilities Proven effective against Norovirus, Influenza A virus, Salmonella enterica and Campylobacter jejuni Efficacious against prevalent hospital pathogens such as Methicillin-Resistant...
2020-02-03 LANXESS product Rely+OnTM VirkonTM effective against coronavirus Stronger demand in Asia and Europe Optimization of production capacities for increased delivery capability Effectiveness of Rely+On Virkon scientifically proven Cologne – The coronavirus continues to spread. Authorities around the world are therefore tightening measures to stop the further spread of the...
Copyright © PHARMACON (PTE) LTD 2022